Pfizer mulling sale of consumer healthcare business: Reuters

(Reuters) – Pfizer Inc (PFE.N) said on Tuesday it was reviewing strategic alternatives for its consumer healthcare business, including a full or partial separation of the unit.

The company said any decision related to the strategic alternatives would be made during 2018.